AKT1 and lung cancer: Consistent with Zhou’s study [25], we chose 30 μM hemin to further delineate the involvement of EGFR-AKT signaling in ICH by studying the effect of afatinib, a second-generation EGFR-TKI for lung cancers [7], in primary cultured cortical neurons.